免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

Global Utilization And Registry Database for Improved preservAtion of doNor Livers

NCT:NCT05082077 · ENROLLING_BY_INVITATION

NCT编号NCT05082077
状态ENROLLING_BY_INVITATION
开始日期2022-03-15
SponsorParagonix Technologies (INDUSTRY)
First posted
Last updated

简要摘要

The objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor liver that were preserved and transported within the LIVERguard system, as well as retrospective standard of care patients

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑